Alcobra Ltd. (Nasdaq: ADHD) announced that it has received the written full clinical hold notice from the Division of Psychiatry ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE